Market Closed -
Nyse
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
1.44
USD
|
-0.69%
|
|
-7.69%
|
-47.06%
|
Fiscal Period: Settembre |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
313.4
|
492.5
|
472.9
|
134
|
59.08
|
77.73
|
-
|
-
|
Enterprise Value (EV)
1 |
313.4
|
492.5
|
472.9
|
134
|
54.93
|
64.46
|
62.4
|
77.73
|
P/E ratio
|
-12.6
x
|
-15.5
x
|
-12.2
x
|
-3.55
x
|
-1.71
x
|
-1.99
x
|
-2.91
x
|
-6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
677
x
|
881
x
|
-
|
-
|
-
|
598
x
|
17
x
|
10.1
x
|
EV / Revenue
|
677
x
|
881
x
|
-
|
-
|
-
|
496
x
|
13.7
x
|
10.1
x
|
EV / EBITDA
|
-
|
-
|
-
|
-4.16
x
|
-2
x
|
-1.6
x
|
-2.53
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-7.1
x
|
-2.37
x
|
-1.64
x
|
-2.38
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
-14.1%
|
-42.3%
|
-61%
|
-42.1%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
4.49
x
|
2.53
x
|
2
x
|
-
|
Nbr of stocks (in thousands)
|
35,055
|
38,624
|
43,028
|
43,367
|
47,260
|
53,979
|
-
|
-
|
Reference price
2 |
8.940
|
12.75
|
10.99
|
3.090
|
1.250
|
1.440
|
1.440
|
1.440
|
Announcement Date
|
12/16/19
|
12/29/20
|
12/21/21
|
12/27/22
|
12/21/23
|
-
|
-
|
-
|
Fiscal Period: Settembre |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.4628
|
0.5587
|
-
|
-
|
-
|
0.13
|
4.567
|
7.7
|
EBITDA
1 |
-
|
-
|
-
|
-32.23
|
-27.52
|
-40.18
|
-24.7
|
-
|
EBIT
1 |
-20.2
|
-28.99
|
-36.19
|
-36.06
|
-31.48
|
-35.81
|
-25.14
|
-16.5
|
Operating Margin
|
-4,364.15%
|
-5,188.32%
|
-
|
-
|
-
|
-27,548.46%
|
-550.47%
|
-214.29%
|
Earnings before Tax (EBT)
1 |
-22.13
|
-30.28
|
-36.36
|
-36.7
|
-32.37
|
-36.56
|
-25.89
|
-16.5
|
Net income
1 |
-22.13
|
-30.28
|
-36.36
|
-37.63
|
-32.37
|
-36.56
|
-25.89
|
-17.5
|
Net margin
|
-4,783.28%
|
-5,419.57%
|
-
|
-
|
-
|
-28,125.38%
|
-566.89%
|
-227.27%
|
EPS
2 |
-0.7100
|
-0.8200
|
-0.9000
|
-0.8700
|
-0.7300
|
-0.7250
|
-0.4950
|
-0.2400
|
Free Cash Flow
1 |
-
|
-
|
-
|
-18.88
|
-23.21
|
-39.33
|
-26.26
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-30,250.77%
|
-575.04%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/16/19
|
12/29/20
|
12/21/21
|
12/27/22
|
12/21/23
|
-
|
-
|
-
|
Fiscal Period: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-8.573
|
-7.741
|
-7.965
|
-6.662
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-8.474
|
-
|
-9.552
|
-8.719
|
-8.948
|
-7.651
|
-8.176
|
-8.182
|
-7.468
|
-6.9
|
-7.2
|
-7
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-8.205
|
-
|
-9.823
|
-9.633
|
-8.462
|
-7.854
|
-8.343
|
-8.367
|
-7.631
|
-7.1
|
-7.4
|
-7.2
|
Net income
1 |
-8.205
|
-8.783
|
-9.823
|
-9.927
|
-9.097
|
-8.025
|
-8.343
|
-8.367
|
-7.631
|
-7.1
|
-7.4
|
-7.2
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.1900
|
-0.2000
|
-0.2300
|
-0.2300
|
-0.2100
|
-0.1800
|
-0.1900
|
-0.1900
|
-0.1600
|
-0.1400
|
-0.1300
|
-0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/21/21
|
2/11/22
|
5/13/22
|
8/12/22
|
12/27/22
|
2/14/23
|
5/12/23
|
8/11/23
|
12/21/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
4.15
|
13.3
|
15.3
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-18.9
|
-23.2
|
-39.3
|
-26.3
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
0.2800
|
0.5700
|
0.7200
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
0.64
|
0.36
|
3.62
|
3.14
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
2,784.62%
|
68.75%
|
-
|
Announcement Date
|
12/16/19
|
12/29/20
|
12/21/21
|
12/27/22
|
12/21/23
|
-
|
-
|
-
|
Last Close Price
1.44
USD Average target price
7.7
USD Spread / Average Target +434.72% Consensus |
1st Jan change
|
Capi.
|
---|
| -47.06% | 77.73M | | -4.66% | 86.13B | | +1.32% | 39.82B | | -19.27% | 30.42B | | +57.86% | 25.23B | | -17.69% | 11.6B | | -43.00% | 11.51B | | -9.14% | 11.95B | | +5.24% | 8.71B | | -8.42% | 8.12B |
Biopharmaceuticals
|